Park, M., Nam, J. S., Kim, T., Yoon, G., Kim, S., Lee, C., Lee, C. G., Park, S., Bejoymohandas, K. S., Yang, J., Kwon, Y. H., Lee, Y. J., Seo, J. K., Min, D., Park, T., & Kwon, T. (2024). Rational Design of Biocompatible Ir(III) Photosensitizer to Overcome Drug‐Resistant Cancer via Oxidative Autophagy Inhibition. Advanced Science. Portico. https://doi.org/10.1002/advs.202407236

Krukenberg, S., Möckl, F., Weiß, M., Dekiert, P., Hofmann, M., Gerlach, F., Winterberg, K. J., Kovacevic, D., Khansahib, I., Troost, B., Hinrichs, M., Granato, V., Nawrocki, M., Hub, T., Tsvilovskyy, V., Medert, R., Woelk, L.-M., Förster, F., Li, H., … Guse, A. H. (2024). MASTER-NAADP: a membrane permeable precursor of the Ca2+ mobilizing second messenger NAADP. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-52024-y

Westerterp, M., Li, F., & Zhang, H. (2023). Dissecting cell type–specific impact in lysosomal acid lipase deficiency–associated disorders. Journal of Lipid Research, 64(12), 100474. https://doi.org/10.1016/j.jlr.2023.100474

Zhan, X., Zhang, H., Maegawa, G. H. B., Wang, Y., Gao, X., Wang, D., & Li, J. (2023). Use of Ambroxol as Therapy for Gaucher Disease. JAMA Network Open, 6(6), e2319364. https://doi.org/10.1001/jamanetworkopen.2023.19364

Chen, J., Soni, R. K., Xu, Y., Simoes, S., Liang, F.-X., DeFreitas, L., Hwang, R., Montesinos, J., Lee, J. H., Area-Gomez, E., Nandakumar, R., Vardarajan, B., & Marquer, C. (2023). Juvenile CLN3 disease is a lysosomal cholesterol storage disorder: similarities with Niemann-Pick type C disease. EBioMedicine, 92, 104628. https://doi.org/10.1016/j.ebiom.2023.104628

Melville, Z., Dridi, H., Yuan, Q., Reiken, S., Wronska, A., Liu, Y., Clarke, O., & Marks, A. (2022). A drug and ATP binding site in type 1 ryanodine receptor. Acta Crystallographica Section A Foundations and Advances, 78(a1), a315–a315. https://doi.org/10.1107/s205327332209684x